The International Vaccine Institute and Intravacc (the Institute for Translational Vaccinology) in The Netherlands “agreed to collaborate on vaccine research and development (R&D) and to promote capacity building in developing nations.” IVI said the collaboration will focus on improving available technologies for vaccine development and in addition on the clinical evaluation and the regulatory process, and that the two parties will work together to create a joint application for funding of a collaborative project. They will also join forces on further development and complement training initiatives in vaccinology for developing countries, including a possible laboratory-oriented course. IVI Director General Dr. Christian Loucq said, “As a signatory country of IVI, the Netherlands has been an important supporter of the organization. This partnership will benefit both Intravacc and IVI in that it furthers our mutual aim to ensure that vaccines are developed and made available to the poor, and in how it deepens our relationship with the Netherlands, a key IVI partner.”

http://www.ivi.org/web/www/07_01?p_p_id=EXT_BBS&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_EXT_BBS_struts_action=%2Fext%2Fbbs%2Fview_message&_EXT_BBS_messageId=585